Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prolactin levels in antipsychotic treatment of patients with schizophrenia carrying the DRD2*A1 allele.

The British journal of psychiatry : the journal of mental science - 1 Aug 2004

Young Ross McD, Lawford Bruce R, Barnes Mark, Burton Simon C, Ritchie Terry, Ward Warren K, Noble Ernest P

Abstract excerpt

BACKGROUND: Hyperprolactinaemia induced by D(2) dopamine receptor antagonist antipsychotic medication can result in significant health problems. AIMS: To examine the role of DRD2 polymorphism on prolactin levels in patients treated with antipsychotic medication. METHOD: Antipsychotic drugs with different degrees of D(2) receptor binding were given to 144 patients with schizophrenia. Serum prolactin levels were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Benzodiazepines

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Clozapine

Share to Dopamine Antagonists

Share to Olanzapine

Share to Prolactin

Share to Receptors, Dopamine D2

Share to Risperidone

Source

Identifiers

PMID: 15286066
DOI: 10.1192/bjp.185.2.147

Genes

DRD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prolactin levels in antipsychotic treatment of patients with schizophrenia carrying the DRD2*A1 allele.PMID 15286066Read ↗

Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia.Semantic proximity Read ↗

Association of DRD2 and ANKK1 polymorphisms with prolactin increase in olanzapine-treated women.Semantic proximity Read ↗

Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents.Semantic proximity Read ↗

Genetic associations of prolactin increase in olanzapine/fluoxetine combination-treated patients.Semantic proximity Read ↗

D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis.Semantic proximity Read ↗

Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene.Semantic proximity Read ↗

Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis.Semantic proximity Read ↗

DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients.Semantic proximity Read ↗

Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidol.Semantic proximity Read ↗

Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia.Semantic proximity Read ↗

Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole.Semantic proximity Read ↗

Analysis of neuroleptic binding affinities and potencies for the different human D2 dopamine receptor missense variantsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.